Mar O’Callaghan

1.3k total citations
26 papers, 489 citations indexed

About

Mar O’Callaghan is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Mar O’Callaghan has authored 26 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Genetics and 6 papers in Clinical Biochemistry. Recurrent topics in Mar O’Callaghan's work include Mitochondrial Function and Pathology (7 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Metabolism and Genetic Disorders (6 papers). Mar O’Callaghan is often cited by papers focused on Mitochondrial Function and Pathology (7 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Metabolism and Genetic Disorders (6 papers). Mar O’Callaghan collaborates with scholars based in Spain, United Kingdom and United States. Mar O’Callaghan's co-authors include Rafael Artuch, Raquel Montero, Judith Armstrong, Mercè Pineda, Mercédes Pineda, Antoni Capdevila, Josep Blanch, Ana Mas, Silvia M. Vidal and Àngels García‐Cazorla and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Brain Pathology.

In The Last Decade

Mar O’Callaghan

25 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mar O’Callaghan Spain 12 273 125 98 86 80 26 489
M. Pineda Spain 13 285 1.0× 67 0.5× 118 1.2× 127 1.5× 111 1.4× 26 533
M. Barth France 12 217 0.8× 128 1.0× 140 1.4× 46 0.5× 33 0.4× 17 423
Jennifer Müller vom Hagen Germany 12 169 0.6× 152 1.2× 37 0.4× 16 0.2× 117 1.5× 15 440
J.F. de Rijk-van Andel Netherlands 10 246 0.9× 75 0.6× 106 1.1× 155 1.8× 146 1.8× 15 497
Deborah Barbouth United States 11 285 1.0× 118 0.9× 412 4.2× 27 0.3× 32 0.4× 32 678
A.-E. Lehesjoki Finland 12 241 0.9× 101 0.8× 310 3.2× 33 0.4× 128 1.6× 16 610
Stefania Zampieri Italy 19 267 1.0× 595 4.8× 64 0.7× 26 0.3× 53 0.7× 34 867
Lemuel Racacho Canada 14 262 1.0× 66 0.5× 116 1.2× 18 0.2× 164 2.0× 18 547
Sofia Hassiotis Australia 15 165 0.6× 454 3.6× 62 0.6× 8 0.1× 48 0.6× 26 602
Delphine Héron France 11 201 0.7× 34 0.3× 157 1.6× 14 0.2× 138 1.7× 27 421

Countries citing papers authored by Mar O’Callaghan

Since Specialization
Citations

This map shows the geographic impact of Mar O’Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mar O’Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mar O’Callaghan more than expected).

Fields of papers citing papers by Mar O’Callaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mar O’Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mar O’Callaghan. The network helps show where Mar O’Callaghan may publish in the future.

Co-authorship network of co-authors of Mar O’Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Mar O’Callaghan. A scholar is included among the top collaborators of Mar O’Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mar O’Callaghan. Mar O’Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casas‐Alba, Dídac, Patricia Rubio, Ana García‐García, et al.. (2024). MECP2 Duplication Syndrome: AI-Based Diagnosis, Severity Scale Development and Correlation with Clinical and Molecular Variables. Diagnostics. 15(1). 10–10.
2.
Artuch, Rafael, Àngels García‐Cazorla, Mar O’Callaghan, et al.. (2024). Genome and RNA sequencing were essential to reveal cryptic intronic variants associated to defective ATP6AP1 mRNA processing. Molecular Genetics and Metabolism. 142(3). 108511–108511. 2 indexed citations
3.
Petazzi, Paolo, Antonio Gómez, Iolanda Scognamiglio, et al.. (2023). Global Impairment of Immediate-Early Genes Expression in Rett Syndrome Models and Patients Linked to Myelination Defects. International Journal of Molecular Sciences. 24(2). 1453–1453. 8 indexed citations
4.
Darling, Alejandra, Pilar Irún, Pilar Giraldo, et al.. (2021). Pediatric Gaucher disease with intermediate type 2–3 phenotype associated with parkinsonian features and levodopa responsiveness. Parkinsonism & Related Disorders. 91. 19–22. 3 indexed citations
5.
O’Callaghan, Mar, et al.. (2021). Unraveling Molecular Pathways Altered in MeCP2-Related Syndromes, in the Search for New Potential Avenues for Therapy. Biomedicines. 9(2). 148–148. 4 indexed citations
6.
Vries, Maaike C. de, David A. Brown, Mitchell E. Allen, et al.. (2020). Safety of drug use in patients with a primary mitochondrial disease: An international Delphi‐based consensus. Journal of Inherited Metabolic Disease. 43(4). 800–818. 40 indexed citations
7.
Urreizti, Roser, Estrella López‐Martín, Antonio Federico Martínez‐Monseny, et al.. (2020). Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum. Orphanet Journal of Rare Diseases. 15(1). 44–44. 21 indexed citations
8.
Sánchez‐Iglesias, Sofía, Melissa K. Crocker, Mar O’Callaghan, et al.. (2019). Celia’s encephalopathy and c.974dupG in BSCL2 gene: a hidden change in a known variant. Neurogenetics. 20(2). 73–82. 8 indexed citations
9.
Vidal, Silvia M., et al.. (2019). Genetic Landscape of Rett Syndrome Spectrum: Improvements and Challenges. International Journal of Molecular Sciences. 20(16). 3925–3925. 45 indexed citations
10.
Pintos‐Morell, Guillem, Javier Blasco‐Alonso, María L. Couce, et al.. (2018). Elosulfase alfa for mucopolysaccharidosis type IVA: Real-world experience in 7 patients from the Spanish Morquio-A early access program. Molecular Genetics and Metabolism Reports. 15. 116–120. 11 indexed citations
11.
Molero-Luís, Marta, Aída Ormazábal, Raquel Montero, et al.. (2018). Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience. Journal of Inherited Metabolic Disease. 41(6). 1147–1158. 12 indexed citations
12.
Pineda, M., et al.. (2016). Clinical Evolution After Enzyme Replacement Therapy in Twins with the Severe Form of Maroteaux–Lamy Syndrome. JIMD Reports. 30. 7–14. 2 indexed citations
13.
Nascimento, A., C. Ortez, Cristina Jou, et al.. (2016). Neuromuscular Manifestations in Mitochondrial Diseases in Children. Seminars in Pediatric Neurology. 23(4). 290–305. 4 indexed citations
14.
Narbona, Juan, Leslie Matalonga, Mireia del Toro, et al.. (2015). A leaky splicing mutation in NFU1 is associated with a particular biochemical phenotype. Consequences for the diagnosis. Mitochondrion. 26. 72–80. 15 indexed citations
15.
Quijada‐Fraile, Pilar, Mar O’Callaghan, Elena Martín‐Hernández, et al.. (2014). Follow-up of folinic acid supplementation for patients with cerebral folate deficiency and Kearns-Sayre syndrome. Orphanet Journal of Rare Diseases. 9(1). 217–217. 31 indexed citations
16.
Yubero, Dèlia, Mar O’Callaghan, Raquel Montero, et al.. (2014). Association between coenzyme Q10 and glucose transporter (GLUT1) deficiency. BMC Pediatrics. 14(1). 284–284. 12 indexed citations
17.
Montero, Raquel, Ana Mas, Mar O’Callaghan, et al.. (2010). Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich’s Ataxia. The Cerebellum. 10(1). 1–8. 114 indexed citations
18.
Pineda, M., Mar O’Callaghan, Marina Vilaseca, et al.. (2009). Clinical experience with miglustat therapy in pediatric patients with Niemann–Pick disease type C: A case series. Molecular Genetics and Metabolism. 99(4). 358–366. 93 indexed citations
19.
Mora, Jaume, María del Mar Pérez Gómez, Esther Geán, et al.. (2009). Axenfeld–Rieger ocular anomaly and retinoblastoma caused by constitutional chromosome 13q deletion. Pediatric Blood & Cancer. 54(3). 480–482. 5 indexed citations
20.
Pineda, M., et al.. (2008). Vanishing White Matter Disease Associated with Progressive Macrocephaly. Neuropediatrics. 39(1). 29–32. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Pineda Breakdown of academic impact, for papers by M. Barth Breakdown of academic impact, for papers by Jennifer Müller vom Hagen Breakdown of academic impact, for papers by J.F. de Rijk-van Andel Breakdown of academic impact, for papers by Deborah Barbouth Breakdown of academic impact, for papers by A.-E. Lehesjoki Breakdown of academic impact, for papers by Stefania Zampieri Breakdown of academic impact, for papers by Lemuel Racacho Breakdown of academic impact, for papers by Sofia Hassiotis Breakdown of academic impact, for papers by Delphine Héron
Rankless by CCL
2026